|
For:
|
Bousquet J, Sousa‐Pinto B, Anto JM, Bedbrook A, Czarlewski W, Ansotegui IJ, Bergmann K, Braido F, Brussino L, Cecchi L, Loureiro CC, Cruz AA, Devillier P, Fiocchi A, Gemicioglu B, Haahtela T, Ivancevich JC, Klimek L, Kulus M, Kuna P, Kupczyk M, Kvedariene V, Larenas‐Linnemann DE, Louis G, Louis R, Makris M, Morais‐Almeida M, Niedoszytko M, Ohta K, Ollert M, Papadopoulos N, Patella V, Pétré B, Pfaar O, Puggioni F, Quirce S, Regateiro FS, Roche N, Rouadi PW, Samolinski B, Sastre J, Schleich F, Scichilone N, Taborda‐Barata L, Toppila‐Salmi S, Valiulis A, Vardaloglu Koyuncu I, Ventura MT, Yorgancioglu A, Fonseca JA, Zuberbier T. Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air®. Clin Transl Allergy 2024;14:e12390. [PMID: 39313483 PMCID: PMC11419846 DOI: 10.1002/clt2.12390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Academic Contribution Register] [Received: 02/21/2024] [Revised: 07/16/2024] [Accepted: 08/05/2024] [Indexed: 09/25/2024] Open |